Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.7 |